University of California San Francisco

Publications

  1. The Interplay Between Circadian Clocks and the Tumour Microenvironment in Breast Cancer.
    Finger AM, Ector C, Weaver VM
    Cancers (Basel). 2026 Mar 12; 18(6).; 
    PubMed
  2. Pancreatic Cancer Progression Involves Increased Lysyl Oxidase-Mediated Collagen Cross-Links as Part of the Desmoplastic Reaction.
    Barrett A, Maslanka MD, Darula Z, McCabe MC, Saviola AJ, Schmitt LR, Weaver V, Pitts TM, Messersmith WA, Hansen KC
    Biochemistry. 2025 08 19; 64(16):3515-3525.; 
    PubMed
  3. NCOR2 represses MHC class I molecule expression to drive metastatic progression of breast cancer.
    Ticha P, Northey JJ, Narain R, Sharma S, Lakins JN, Gonzalez H, Kersten K, Ironside AJ, Drain AP, Zidek M, Tsai KK, Chen YY, Shenderov E, Weaver VM
    Nat Commun. 2026 May 05; 17(1).; 
    PubMed
  4. Proteomic characterization of type I collagen N-terminal crosslinked peptides.
    Darula Z, McCabe MC, Barrett A, Schmitt LR, Maslanka MD, Saviola AJ, Orgel J, Burlingame A, Staab-Weijnitz CA, Stenmark K, Weaver V, Chalkley RJ, Hansen KC
    Matrix Biol Plus. 2025 Aug; 27:100179.; 
    PubMed
  5. Resolving fibrosis by stimulating HSC-dependent extracellular matrix degradation.
    Sharma S, Prathigudupu V, Cable C, Serrano LR, Nerella S, Chen A, Hassan G, Lakins J, Valenzuela CL, Tsukui T, Ramamoorthi R, Kim JJ, Willenbring H, Mattis AN, Volk RF, Zaro BW, Coon JJ, Beresis R, DeGrado WF, Weaver VM, Christenson SA, Jo H, Chen JY
    Sci Transl Med. 2025 Aug 27; 17(813):eads9470.; 
    PubMed
  6. Mechanical regulation of extracellular vesicle activity during tumour progression.
    Parihar K, Liu DA, Hassan G, Issadore DA, Janmey PA, Weaver VM, Guo W, Radhakrishnan R
    Nat Biomed Eng. 2025 Aug; 9(8):1202-1221.; 
    PubMed
  7. Tissue tension fosters macrophage-driven lipid peroxidation-induced DNA damage.
    Hayward MK, Northey JJ, Opazo-Mellado V, Stashko C, Maller O, Ironside AJ, Que X, Lakins JN, Hwang ES, Witztum JL, Gonzalez H, Weaver VM
    Cancer Cell. 2026 Jun 08; 44(6):1255-1269.e9.; 
    PubMed
  8. Axonal injury is a targetable driver of glioblastoma progression.
    Clements M, Tang W, Florjanic Baronik Z, Simpson Ragdale H, Oria R, Volteras D, White IJ, Beattie G, Uddin I, Lenn T, Lindsay R, Castro Devesa S, Karamched SR, Lythgoe MF, Shahrezaei V, Weaver VM, Sugisawa R, Roncaroli F, Marguerat S, Hill CS, Parrinello S
    Nature. 2025 10; 646(8084):452-461.; 
    PubMed
  9. Inactivation of CDKN2AARF Promotes p53-Independent Remodeling of the PDAC Tumor Microenvironment.
    Ferreira S, Flowers BM, Choi WY, Farina-Morillas M, Gatto A, Bhattacharyya S, Boross G, Hassan G, Mulligan AS, Vogel H, Wood LD, Weaver VM, Winslow MM, Petrov DA, Sherman MH, Choi HY, Hayes DN, Aguirre AJ, Seoane JA, Attardi LD
    Cancer Res. 2026 Jul 02; 86(13):3109-3122.; 
    PubMed
  10. A STAT3/integrin axis accelerates pancreatic cancer initiation and progression.
    Campos AD, Shepard RM, Ortega Z, Heumann I, Wilke AE, Nam A, Cable C, Kouhmareh K, Klemke R, Mattson NM, Ideker T, De Arruda Saldanha C, Heinz S, Weaver V, Von Schalscha T, Wettersten HI, Weis SM, Cheresh DA
    Cell Rep. 2025 Aug 26; 44(8):116010.; 
    PubMed